Careers  |  Sign In  |  Register

Latest in Infectious Diseases

A Phase III clinical trial for a shingles vaccine known as HZ/su involving over 16,000 people reduced the risk of shingles by 97.2 percent in adults ages 50 and older, Reuters reports. The vaccine, developed by GlaxoSmithKline, combines a protein found on the virus with a booster intended to enhance...
According to CBS News, a new study shows that male Ebola survivors should make sure to wear condoms during sex for at least three months after recuperating from the illness. The study, published in Reproductive Sciences, confirmed the current recommendations in place for sexual activity after Ebola survival,...
In an effort to increase the amount of time doctors and nurses can battle the tropical heat while treating Ebola, 1,500 submissions have been made to the Ebola "Grand Challenges" Contest, reports The New York Times. The contest has seen submissions such as  an Ebola-repellant lotion, protective gear...